Physician profile
John Thachil
NPI 1710920160
$9,676.61
in general payments reported to CMS, 2019-2025
70 companies · $3,140 in 2025
The $3,140 reported for 2025 was more than what 75% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $104 · 2021: $11.92 · 2022: $1,525 · 2023: $2,128 · 2024: $2,767 · 2025: $3,140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,418 · Education: $617.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,418.30 |
| Education | $616.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $693.85 | 2022-2025 | Reblozyl, Opdualag, Opdivo |
| Janssen Biotech, INC. | $692.47 | 2022-2025 | Rybrevant, Erleada, Darzalex |
| Novartis Pharmaceuticals Corporation | $657.33 | 2022-2025 | |
| Astrazeneca Pharmaceuticals Lp | $578.09 | 2022-2025 | Enhertu, Lynparza, Calquence |
| Pfizer INC. | $544.37 | 2022-2025 | |
| Abbvie INC. | $519.51 | 2022-2025 | Venclexta |
| Astellas Pharma US INC | $415.24 | 2022-2025 | Padcev, Xtandi, Vyloy |
| Seagen INC. | $405.06 | 2019-2025 | Padcev |
| Daiichi Sankyo INC. | $355.78 | 2023-2025 | Enhertu, Datroway, Vanflyta |
| Tempus Ai, INC | $354.85 | 2024-2025 | Xt Cdx |
| E.R. Squibb & Sons, L.L.C. | $345.83 | 2022-2025 | Opdivo, Opdualag |
| Merck Sharp & Dohme LLC | $246.06 | 2023-2025 | Keytruda, Welireg, Lynparza |
| Taiho Oncology, INC. | $234.59 | 2023-2025 | |
| Eisai INC. | $230.75 | 2022-2025 | |
| Beigene USA, INC. | $223.33 | 2023-2025 | Brukinsa |
Show all 70 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $195.14 | 2022-2024 | |
| Array Biopharma INC | $190.49 | 2022-2025 | Mektovi, Braftovi, Lorbrena |
| Genentech USA, INC. | $188.25 | 2022-2025 | Tecentriq, Alecensa, Rozlytrek |
| Gilead Sciences, INC. | $166.17 | 2021-2025 | Trodelvy |
| Glaxosmithkline, LLC. | $153.47 | 2022-2025 | Ojjaara, Blenrep |
| Beone Medicines USA, INC. | $137.14 | 2025 | Brukinsa, Tevimbra |
| Lilly USA, LLC | $118.33 | 2022-2025 | Verzenio, Jaypirca, Retevmo |
| Springworks Therapeutics, INC. | $105.41 | 2024-2025 | Ogsiveo, Gomekli |
| Pharmacosmos Therapeutics INC. | $99.22 | 2023-2025 | Monoferric |
| Incyte Corporation | $92.16 | 2022-2025 | Jakafi, Monjuvi |
| Pharmaessentia USA Corporation | $83.90 | 2022-2025 | Besremi |
| Regeneron Healthcare Solutions, INC. | $77.53 | 2024-2025 | Libtayo, Lynozyfic |
| Morphosys, US INC. | $77.10 | 2022-2023 | Monjuvi |
| Agios Pharmaceuticals, INC. | $74.41 | 2025 | Pyrukynd |
| Rigel Pharmaceuticals, INC. | $73.22 | 2024-2025 | Rezlidhia, Tavalisse, Tavalisse |
| Bayer Healthcare Pharmaceuticals INC. | $72.67 | 2022-2025 | |
| Fennec Pharmaceuticals, INC. | $60.12 | 2023-2024 | Pedmark |
| Blueprint Medicines Corporation | $59.53 | 2025 | Ayvakit |
| Amgen INC. | $59.15 | 2022-2023 | Lumakras |
| Boston Scientific Corporation | $58.33 | 2023-2025 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Cti Biopharma Corp. | $56.49 | 2022-2023 | Vonjo |
| Deciphera Pharmaceuticals INC. | $51.16 | 2024-2025 | Qinlock, Romvimza |
| Geron Corporation | $47.14 | 2025 | Rytelo |
| Servier Pharmaceuticals LLC | $46.69 | 2024-2025 | |
| Aveo Pharmaceuticals, INC. | $44.07 | 2022-2025 | |
| Recordati_rare_diseases_inc. | $43.92 | 2025 | Enjaymo |
| Tersera Therapeutics LLC | $43.59 | 2024-2025 | Zoladex, Xermelo |
| Stemline Therapeutics INC. | $40.04 | 2025 | Orserdu |
| Legend Biotech USA INC. | $36.24 | 2024-2025 | Carvykti |
| Adc Therapeutics America, INC. | $36.15 | 2023-2024 | |
| Kyowa Kirin, INC. | $35.87 | 2023 | Poteligeo |
| Sirtex Medical INC | $34.73 | 2023 | Sir-Spheres Microspheres |
| Sobi, INC | $34.68 | 2024 | |
| Syndax Pharmaceuticals, INC. | $34.20 | 2025 | |
| Dendreon Pharmaceuticals LLC | $32.17 | 2024 | Provenge |
| Puma Biotechnology, INC. | $31.32 | 2024 | |
| Iovance Biotherapeutics, INC. | $30.41 | 2025 | Amtagvi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.32 | 2019 | |
| Tolmar, INC. | $27.67 | 2023 | |
| Tactile Systems Technology INC | $27.24 | 2022-2023 | Entre Plus, Flexitouch Plus |
| Takeda Pharmaceuticals U.S.A., INC. | $26.81 | 2024 | Fruzaqla |
| Invivyd INC | $24.55 | 2025 | Pemgarda |
| Inari Medical, INC. | $23.42 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Karyopharm Therapeutics INC. | $22.91 | 2024 | Xpovio |
| Jazz Pharmaceuticals INC. | $20.74 | 2024 | |
| Genmab U.S., INC. | $18.82 | 2024 | Epkinly |
| Emd Serono, INC. | $18.28 | 2024 | |
| Amneal Pharmaceuticals LLC | $17.43 | 2025 | Alymsys |
| Mirati Therapeutics, INC. | $17.01 | 2023 | Krazati |
| Ipsen Biopharmaceuticals, INC | $16.80 | 2025 | Onivyde |
| Myriad Genetic Laboratories, INC. | $15.90 | 2023 | Myrisk |
| Shield Therapeutics INC | $15.07 | 2024 | |
| Telix Pharmaceuticals | $14.46 | 2023 | Illuccix |
| Janssen Pharmaceuticals, INC | $12.66 | 2023 | Xarelto |
| Clovis Oncology, INC. | $10.80 | 2019 |
Drugs and devices associated with these payments
Enhertu $435Brukinsa $335Kisqali $311Lonsurf $235Inqovi $235Keytruda $231Xt Cdx $228Imbruvica $223Rybrevant $209Reblozyl $209Erleada $203Padcev $195Lenvima $175Opdualag $168Opdivo $163Ibrance $155Mektovi $149Braftovi $149Venclexta $148Tukysa $146Elrexfio $146Lynparza $142Epkinly $139Adcetris $124Lorbrena $121Darzalex $109Fabhalta $105Xalkori $101Monoferric $99.22Verzenio $97.76Jaypirca $97.76Enjaymo $94.45Ojjaara $92.56Xtandi $86.28Welireg $84.91Sarclisa $78.18Ogsiveo $76.65Pyrukynd $74.41Tavalisse $73.22Rezlidhia $73.22Vonjo $71.53Trodelvy $71.24Akeega $69.05Promacta $67.24Monjuvi $65.69Besremi $63.46Pedmark $60.12Ayvakit $59.53Therasphere Y90 Glass Microspheres 10 Gbq $58.33Libtayo $57.33Gavreto $56.92Tecvayli $56.51Qinlock $51.16Calquence $50.32Retevmo $50.20Tecentriq $49.17Rozlytrek $49.17Alecensa $49.17Rytelo $47.14Vyloy $46.56Oxbryta $44.91Piqray $44.08Bosulif $43.70Tagrisso $40.89Orserdu $40.04Lunsumio $39.11Columvi $39.11Polivy $39.11Xospata $38.76Orgovyx $38.70Datroway $36.82Poteligeo $35.87Jakafi $35.42Sir-Spheres Microspheres $34.73Pomalyst $32.94Provenge $32.17Amtagvi $30.41Carvykti $30.26Cablivi $29.95Vanflyta $29.90Talzenna $29.19Illuccix $28.92Gomekli $28.76Blenrep $28.73Eligard $27.67Stivarga $27.25Vitrakvi $27.25Fruzaqla $26.81Romvimza $26.03Talvey $25.49Tevimbra $25.34Pemgarda $24.55Zoladex $24.07Xofigo $23.87Nubeqa $23.87Ct Thrombectomy System Kit $23.42Flowtriever Catheter, S $23.42Imfinzi $23.22Xpovio $22.91Emrelis $22.59
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Thachil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.